Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lechat

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Therapie|January 15, 2005
[Clinical trials of beta-blockers in heart failure: history, overview and future prospects]Philippe Lechat
Therapie|January 15, 2005
[From ischaemia to heart failure: heart rate--actor or stamper?]Philippe Lechat
Therapie|December 18, 2021
Lessons from the COVID-19 pandemicPhilippe Lechat
European Journal of Drug Metabolism and Pharmacokinetics|August 19, 2022
Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence MethodologyPhilippe Lechat
European Journal of Drug Metabolism and Pharmacokinetics|January 20, 2023
Response to Comment on "Interchangeability Between Generic and Reference Products: Limits of Average Bioequivalence Methodology"Philippe Lechat
Therapie|June 26, 2015
[Pharmacological Basis for Therapeutics. Pharmacological Analysis of Summary of Product Characteristics (SPC) for Physicians]Philippe Lechat
Therapie|March 21, 2017
[DocaMED smartphone app/Internet website on medicines and their therapeutic indications]Philippe Lechat, Sophie Ravoire
Therapie|August 20, 2011
How to improve the clinical development paradigm and its division into phases I, II and IIIMarion Bamberger, Nicholas Moore, Philippe Lechat, et al.
Therapie|November 1, 2012
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of SafetyGilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Pharmacological Research|February 3, 2005
Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive ratsNathalie Mougenot, Odile Médiani, Philippe Lechat
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Therapie|January 15, 2005
[Clinical trials of beta-blockers in heart failure: history, overview and future prospects]Philippe Lechat
Therapie|January 15, 2005
[From ischaemia to heart failure: heart rate--actor or stamper?]Philippe Lechat
Therapie|December 18, 2021
Lessons from the COVID-19 pandemicPhilippe Lechat
European Journal of Drug Metabolism and Pharmacokinetics|August 19, 2022
Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence MethodologyPhilippe Lechat
European Journal of Drug Metabolism and Pharmacokinetics|January 20, 2023
Response to Comment on "Interchangeability Between Generic and Reference Products: Limits of Average Bioequivalence Methodology"Philippe Lechat
Therapie|June 26, 2015
[Pharmacological Basis for Therapeutics. Pharmacological Analysis of Summary of Product Characteristics (SPC) for Physicians]Philippe Lechat
Therapie|March 21, 2017
[DocaMED smartphone app/Internet website on medicines and their therapeutic indications]Philippe Lechat, Sophie Ravoire
Therapie|August 20, 2011
How to improve the clinical development paradigm and its division into phases I, II and IIIMarion Bamberger, Nicholas Moore, Philippe Lechat, et al.
Therapie|November 1, 2012
Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of SafetyGilles Paintaud, Marine Diviné, Philippe Lechat, et al.
Pharmacological Research|February 3, 2005
Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive ratsNathalie Mougenot, Odile Médiani, Philippe Lechat
Pageof 11